Priorities for public health action in the European Union

Priorities for public health action in the European Union

Monoclonal antibodies 19-9 and C-50 were used to assay the cancer associated tumour antigens CA 19-9 and CA-50 in plasma from patients with confirmed pancreatic cancer, and related to the blood group and Lewis blood cell status. The plasma expressions of CA 19-9 or CA-50 were similar, including cases where the patients had Lewis phenotype Le (a-b-). However, analyses of both the tumour antigens...

Mental health in the enlarged European Union: need for relevant public mental health action.

the European Union (EU), which as a result will comprise 25 culturally quite different countries. Each enlargement of the EU so far has been a difficult experience for both the existing member states and the new entrants, since each membership change has altered the structure and the sharing of costs and benefits of membership. Furthermore, each new member brings its own traditions, preferences...

Public health and epidemiological research: a blind spot among the European Union priorities?

Strategies for public health research in European Union countries.

INTRODUCTION 'Health' is an identifiable theme within the European Union multi-annual research programmes. Public Health Innovation and Research in Europe (PHIRE), led by the European Public Health Association, sought to identify public health research strategies in EU member states. METHODS Within PHIRE, national public health associations reviewed structures for health research, held stakeh...

National action for European public health research.

INTRODUCTION Research and innovation are the basis for improving health and health services. The European Union (EU) supports research through multi-annual programmes. Public Health Innovation and Research in Europe (PHIRE) investigated how European countries cooperate for action in public health research. METHODS In PHIRE, following stakeholder workshops and consultations, a national report ...